Clinical Trial Update: A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function [Phase 1]

View source ↗

Summary

A completed Phase 1 study assessing pharmacokinetics and safety of LY3537982 in participants with renal insufficiency compared to those with normal kidney funct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• LY3537982

Snippet

Sponsor: Eli Lilly and Company | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED